Renew Biotechnologies Advances Epigenetic Diagnostics Through Launch of Path Fertility's NOA Guide

PLEASANT GROVE, Utah, Jan. 29, 2026 /PRNewswire/ -- Renew Biotechnologies (Renew) today announced its role as the clinical testing provider for Path Fertility's NOA Guide, a newly launched epigenetic diagnostic test designed to inform surgical decision-making for men with non-obstructive…